13F filing recap · Q1 2011
What did Fairholme Capital Management buy in Q1 2011?
Reported stock-position changes between this filing and the previous one. US-listed stocks across every Fairholme account, including accounts that belong to no fund below.
Stock value
$14.44B
Positions
28
Estimated turnover
34.8%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
BAMBrookfield Corporation$892.65Mreported value+27.50M sharesCSCOCisco Systems, Inc.$614.29Mreported value+35.82M sharesAIG WSAmerican International Group, Inc.$264.03Mreported value+23.72M sharesTELFYTelefonica S.a.$20.62Mreported value+817.5K sharesLLYEli Lilly & Co$7.35Mreported value+209.0K sharesBMYBristol-Myers Squibb Company$7.32Mreported value+277.0K sharesGSKGsk Plc$7.30Mreported value+190.0K sharesAZNAstrazeneca Plc$7.15Mreported value+155.0K shares